Recently, the Hurun Research Institute released the Hurun Future Unicorns – China Cheetah Index 2025. Suzhou Leadsynbio Technology Co.,Ltd. was successfully selected for the list due to its continuous innovation and outstanding commercialization achievements in the field of synthetic biology. The honor also confirms the high recognition of its future value by international authoritative institutions.

Since it was founded, Leadsynbio has focused on developing biomanufacturing processes for active pharmaceutical ingredients (APIs), intermediates, and nutritional products, and providing global customers with green, sustainable, and cost-effective biomanufacturing products. We have built a “R&D-production-supply” full industrial chain system, forming a solid global competitive barrier. Currently, Leadsynbio has achieved large-scale and stable supply of more than ten products, which are widely used in pharmaceuticals, health nutrition and other fields. And our business network has covered many countries and regions around the world, occupying a dominant position in the market.

In the future, Leadsynbio will adhere to innovation-driven development, continuously expand our product pipeline with independent intellectual property rights and further consolidate our full-chain capabilities. We are going to accelerate our global market layout and work with more partners to jointly promote the high-quality development of the industry.